Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  Includes 185,677 shares of Common Stock issuable upon the exercise of the Pre-Funded Warrants (as defined in Item 4). As more fully described in Item 4, the Pre-Funded Warrants are subject to a 9.99% Beneficial Ownership Blocker and certain Warrants are subject to a 4.99% Beneficial Ownership Blocker, and the percentage set forth in row (11) gives effect to such Beneficial Ownership Blockers (as defined in Item 4). The shares reported in rows (6), (8) and (9) show the number of shares of Common Stock issuable upon exercise of such reported securities, giving effect to the Beneficial Ownership Blockers.


SCHEDULE 13G




Comment for Type of Reporting Person:  Includes 367,853 shares of Common Stock issuable upon the exercise of the Pre-Funded Warrants (as defined in Item 4). As more fully described in Item 4, the Pre-Funded Warrants are subject to a 9.99% Beneficial Ownership Blocker and certain Warrants are subject to a 4.99% Beneficial Ownership Blocker, and the percentage set forth in row (11) gives effect to such Beneficial Ownership Blockers (as defined in Item 4). The shares reported in rows (6), (8) and (9) show the number of shares of Common Stock issuable upon exercise of such reported securities, giving effect to the Beneficial Ownership Blockers.


SCHEDULE 13G




Comment for Type of Reporting Person:  Includes 185,677 shares of Common Stock issuable upon the exercise of the Pre-Funded Warrants (as defined in Item 4). As more fully described in Item 4, the Pre-Funded Warrants are subject to a 9.99% Beneficial Ownership Blocker and certain Warrants are subject to a 4.99% Beneficial Ownership Blocker, and the percentage set forth in row (11) gives effect to such Beneficial Ownership Blockers (as defined in Item 4). The shares reported in rows (6), (8) and (9) show the number of shares of Common Stock issuable upon exercise of such reported securities, giving effect to the Beneficial Ownership Blockers.


SCHEDULE 13G



 
Iroquois Capital Management, LLC
 
Signature:/s/ Richard Abbe
Name/Title:Richard Abbe, President
Date:06/16/2025
 
Richard Abbe
 
Signature:/s/ Richard Abbe
Name/Title:Richard Abbe
Date:06/16/2025
 
Kimberly Page
 
Signature:/s/ Kimberly Page
Name/Title:Kimberly Page
Date:06/16/2025
Exhibit Information

Exhibit 1 Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

c113019_ex-1.htm